| Literature DB >> 29519621 |
Almudena García-Ortiz1, Juan M Serrador2.
Abstract
Nitric oxide (NO) is a key messenger in the pathogenesis of inflammation, linking innate and adaptive immunity. By targeting signaling molecules, NO from inducible NO synthase (iNOS) and endothelial (e)NOS affects T helper cell differentiation and the effector functions of T lymphocytes, and is a potential target for therapeutic manipulation. In this review we discuss the regulatory actions exerted by NO on T cell functions, focusing on S-nitrosylation as an important post-translational modification by which NO acts as a signaling molecule during T cell-mediated immunity. We also present recent findings showing novel mechanisms through which NO regulates the activation of human T cells, and consider their potential in strategies to treat tumoral, allergic, and autoimmune diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29519621 DOI: 10.1016/j.molmed.2018.02.002
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951